Chemist Brian Bachmann Charts Path to Personalized Treatment

In this episode, Provost Raver welcomes chemist Brian Bachmann, who is the principal investigator for the Vanderbilt Laboratory for Biosynthetic Studies. Bachmann talks about his work discovering useful chemicals made from natural products (compounds made by tiny living things like bacteria and fungi) that are paving new avenues for drug discovery. He also unpacks how he is using biosynthesis to identify individuals’ specific type/combination of cancers. Bachmann envisions a near future where each cancer case is managed individually, moving beyond the traditional approach of location-based treatments. Join us to learn why “conjugal lagoons,” “molecular choreography” and “stealing IP from molecules” will help make his vision a reality. 

The Quantum Potential podcast is produced by Vanderbilt University. The leadership team includes Metanoya Z. Webb, director of content and editorial strategy for this episode, and Sydney Jones-Wright, director of academic affairs communications. Patrick Sams is the senior social media specialist, and Maisie Wilson is the senior creative project manager. Mike Todd is the university visual media manager.

Special thanks to Jad Abumrad, Vanderbilt University Distinguished Research Professor of Communication of Science and Technology and the executive producer of the Quantum Potential podcast and video series. We also want to thank Major Jackson, Gertrude Conaway Vanderbilt Professor of English, for lending his voice to the end credits for this episode.

For more information about Quantum Potential, go to vanderbilt.edu/quantumpotential/podcast.

The views and opinions expressed by guests on this podcast are their own and do not necessarily reflect those of the host or Vanderbilt University.

Copyright 2025, Vanderbilt University.

Follow Vanderbilt on Social Media: http://social.vanderbilt.edu/